 |
|
Oral Administration of Cilostazol Increases Ocular Blood Flow in Patients with Diabetic Retinopathy
Duck Jin Hwang, Joo Young Shin, Hyeong Gon Yu
Korean J Ophthalmol. 2017;31(2):123-131. Published online 2017 Mar 21 DOI: https://doi.org/10.3341/kjo.2017.31.2.123
|
|
Citations to this article as recorded by
 Bimatoprost Ophthalmic Solution (BOS) 0.3 mg w/v for 1 Open Trial of Long-term Preventive Therapy of Migraine in 3 patients with Pathophysiologic Shift from Brain to Eye
Gupta Vinod Kumar
Journal of Neuroscience and Neurological Disorders.2023; 7(2): 134. CrossRef Cilostazol protects against acetic acid-induced colitis in rats: Possible role for cAMP/SIRT1 pathway
Shimaa M. Elshazly, Ahmed E.M. Elhassanny, Nevertyty M. Mahmoud
European Journal of Pharmacology.2020; 881: 173234. CrossRef Time Course in Ocular Blood Flow and Pulse Waveform in a Case of Ocular Ischemic Syndrome with Intraocular Pressure Fluctuation
Ryo Yamazaki, Ryuya Hashimoto, Hidetaka Masahara, Masashi Sakamoto, Takatoshi Maeno
Vision.2020; 4(2): 31. CrossRef Cilostazol Attenuates Retinal Oxidative Stress and Inflammation in a Streptozotocin-Induced Diabetic Animal Model
Po-Ting Yeh, Yu-Hsun Huang, Shu-Wen Chang, Lu-Chun Wang, Chung-May Yang, Wei-Shiung Yang, Chung-Wu Lin, Chang-Hao Yang
Current Eye Research.2019; 44(3): 294. CrossRef
|